In the context of acute heart failure and CRS, elevated cystatin C values are a decent predictor of post-discharge outcomes and can serve as a valuable tool in stratifying patients based on risk of adverse post-discharge outcomes. This evidence concerns the gene CST3 and congenital rubella syndrome.